Clinical trial
A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
NCT06980025 is registered in ClinicalTrials.gov with The George Washington University Biostatistics Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
- Lead sponsor
- The George Washington University Biostatistics Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 1, 2025
- Completion date
- February 28, 2029
- Enrollment
- 1,800 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
obstetrical complications, preterm delivery